"The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter "...
DOSAGE AND ADMINISTRATION
The dose is 1 – 2 drops in each eye 4 – 6 times a day at regular intervals.
One drop contains approximately 1.6 mg cromolyn sodium.
Patients should be advised that the effect of cromolyn sodium ophthalmic solution therapy is dependent upon its administration at regular intervals, as directed.
Symptomatic response to therapy (decreased itching, tearing, redness, and discharge) is usually evident within a few days, but longer treatment for up to six weeks is sometimes required. Once symptomatic improvement has been established, therapy should be continued for as long as needed to sustain improvement.
If required, corticosteroids may be used concomitantly with cromolyn sodium ophthalmic solution.
FOR OPHTHALMIC USE ONLY
Crolom® (cromolyn sodium ophthalmic solution USP, 4%) is supplied in a plastic bottle individually cartoned with a controlled drop tip in the following sizes:
10 mL bottle (NDC 24208-300-10) - AB30709
DO NOT USE IF IMPRINTED NECKBAND IS NOT INTACT.
Store between 15°-30°C (59°-86°F). Protect from light – store in original carton. Keep tightly closed. Replace cap immediately after use.
KEEP OUT OF REACH OF CHILDREN.
STERILE OPHTHALMIC SOLUTION
Bausch & Lomb Incorporated. Tampa, Florida 33637.
Last reviewed on RxList: 6/1/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Crolom Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.